The arrival of nafithromycin, the nation’s initial homegrown macrolide antibiotic currently waiting for final endorsement from the Central Drugs Standard Control Organization (CDSCO), will mark a crucial moment in the battle against antimicrobial...
The Clinical Trial Supplies market is driven by advanced technologies like blockchain and IoT in supply chain management. The market is projected to increase from US$2.70 Bn in 2024 to US$4.79 Bn by 2033, achieving a CAGR of 6.58% throughout the...
The market for generic pharmaceuticals is experiencing notable expansion driven by the rising demand for affordable medications and advancements in drug production. Most generic medications fall under the category of prescription drugs. According...
The pharmaceuticals industry, along with mobile phones and food processing, demonstrated robust performance since these three together constitute more than 75 percent of all jobs generated. According to an Indian Express report referencing RTI...
The segment of medical devices is expected to grow the quickest in the Nano Biotechnology Market. With the progress of medical technology, the incorporation of nano-engineered materials in diagnostic equipment, wound care products, and biosensors...
The growth of the Marine Derived Pharmaceuticals Market is fueled by heightened investments in marine biotechnologies and the growing need for innovative natural medicines sourced from marine life, including sponges, corals, and deep-sea bacteria...
The domestically created E-beam technology can enable India to become a worldwide leader in the sterilization of medical devices and various radiation-related applications. India reached a significant milestone when the electron beam (E-beam)...
The expanding pipeline of small molecule medications, their rising intricacy, and the requirement for specialized knowledge are fueling the demand for pharmaceutical contract manufacturing in the fill-finish sector. Moreover, with a greater focus...
The global increase in investment, consequently fueling a significant recovery in developed markets, is observed as a vital market driver for the pharmaceutical-grade synthetic camphor market. Nonetheless, the change in positive market sentiments...
Biocon Biologics, a branch of Biocon, has gained access to the market for the biosimilar Ustekinumab in Europe, the United Kingdom (UK), Canada, and Japan. Ustekinumab is a human monoclonal antibody that inhibits the irregular regulation of...
, CDSCO.jpg)
